Background:
Squamous cell carcinoma of the anal canal (SCAC) is a rare cancer with limited effective treatments. Immune checkpoint inhibitors (ICIs) use is routine for recurrent/refractory disease, but predictive biomarkers remain elusive. We analyzed the largest dataset of SCAC to date, focusing on PD-L1 expression.